{"version":"1.0","provider_name":"UNC Chlamydia Vaccine Initiative","provider_url":"https:\/\/www.med.unc.edu\/cvi","author_name":"Kate Matthews","author_url":"https:\/\/www.med.unc.edu\/cvi\/author\/kate-matthews\/","title":"Project 3: Biomarkers of Chlamydial Susceptibility and Disease - UNC Chlamydia Vaccine Initiative","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"SQEypnc0zD\"><a href=\"https:\/\/www.med.unc.edu\/cvi\/projects-and-cores\/project3\/\">Project 3: Biomarkers of Chlamydial Susceptibility and Disease<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.med.unc.edu\/cvi\/projects-and-cores\/project3\/embed\/#?secret=SQEypnc0zD\" width=\"600\" height=\"338\" title=\"&#8220;Project 3: Biomarkers of Chlamydial Susceptibility and Disease&#8221; &#8212; UNC Chlamydia Vaccine Initiative\" data-secret=\"SQEypnc0zD\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/* ]]> *\/\n<\/script>\n","description":"Principal Investigators: Catherine O&#8217;Connell, PhD, and Xiaojing Zheng, PhD Co-Investigators: Quefeng Li, PhD, Xinxia Peng, PhD, and Tim Waterboer, PhD The rationale for this project is that identifying biomarkers of susceptibility to ascending infection and risk for subsequent immune pathology will accelerate rational vaccine design and testing by: 1) identifying individuals most likely benefiting from &hellip; Read more"}